MedTrace Logo

Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy

NCT03620513 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2020-03-09

No results posted yet for this study

Summary

Fiberoptic laryngoscopy (FOL) is one of the most common procedure done in an Ear Nose Throat (ENT) clinic. Topical anesthesia or decongestant or both have been used to improve patient comfort level during the procedure. Recently, role of these agents has been questioned. The investigators would like to study whether topical anesthesia or decongestant or their combination provide any benefit to the patients undergoing FOL.

Conditions

  • Throat Disorder

Interventions

DRUG

Decongestant (oxymetazoline 0.05%)

As described in arm/group

DRUG

Anesthesia (Lidocaine 15%)

As described in arm/group

DRUG

Decongestants and Anesthesia (oxymetazoline and lidocaine)

As described in arm/group

DRUG

Normal saline

Spray of normal saline as premedication

Sponsors & Collaborators

  • Lumbini Medical College

    lead OTHER

Principal Investigators

  • Anup Acharya, MS · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-01-16
Completion
2019-02-16

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03620513 on ClinicalTrials.gov